Abivax
Kinam Hong is a Partner at the Crossover Fund Sofinnova.
This person is not in the org chart
This person is not in any offices
Abivax
Abivax SA is a clinical-stage, publicly traded biotechnology company harnessing the immune system to develop novel treatments against inflammatory diseases, viral diseases and cancer.